✦ LIBER ✦

Investigation of the clinical breakpoints of piperacillin–tazobactam against infections caused byPseudomonas aeruginosa

✍ Scribed by Yuka Yamagishi; Michinori Terada; Emiko Ohki; Yoko Miura; Takumi Umemura; Hiroshige Mikamo

Publisher: Springer
Year: 2012
Tongue: English
Weight: 159 KB
Volume: 18
Category: Article
ISSN: 1341-321X
DOI: 10.1007/s10156-011-0285-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infections caused byPseudomonas aerugino

Infections caused byPseudomonas aeruginosa: Relatively frequent isolation of serogroup 12 from clinical specimens

✍ A. Giammanco; R. Stefano; S. Arista; A. Sinatra; A. Chiarini 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 423 KB

Serological typing of P. aeruginosa is the most simple and reliable procedure recommended for ~ in-house ,, investigations and for studies of suspected outbreaks of infection by this microorganism. It is also a useful procedure in order to know serotype prevalence in a definite geografical area and

Review of piperacillin/tazobactam in the

Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy

✍ P. Charbonneau 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 660 KB

Ciprofloxacin in the treatment of urinar

Ciprofloxacin in the treatment of urinary tract infections caused byPseudomonas aeruginosa and multiresistant bacteria

✍ Saavedra, S. ;Ramírez-Ronda, C. H. ;Nevárez, M. 📂 Article 📅 1986 🏛 Springer-Verlag ⚖ 283 KB